Меню
Набор по приглашению NCT06828549

MObile Support Adapted to Individual Contexts

Без фазы С лечением Type 2 Diabetes

Ориентир для пациента и семьи

Простыми словами

Автоматическая сводка по структурированным данным реестра. Она помогает сориентироваться, но не заменяет официальный протокол или оценку врача.

Что изучают
В протоколе указаны: MOSAIC, Print Materials.
Кому может быть актуально
Состояния в реестре: Type 2 Diabetes. Базовые параметры: 18 лет — 75 лет · Все.
Что важно проверить
Возраст, диагноз и пол — только базовые ориентиры. Предыдущее лечение, анализы и другие обязательные условия указаны ниже в критериях участия.
Где проводится
США
Следующий шаг
Сохраните исследование, покажите его лечащему врачу и уточните актуальный статус у исследовательского центра. Расходы, документы и поездка →
Официальное название

MObile Support Adapted to Individual Contexts (MOSAIC Study)

Обзор

This behavioral clinical trial evaluates an adaptively tailored, mobile phone-delivered intervention (MOSAIC) designed to support adults managing their type 2 diabetes. Adaptive means the intervention can change over time. Tailored means the intervention may be different for different participants. The main questions the study will aim to answer are: 1. Does the diabetes education and support delivered via the MOSAIC adaptive mobile phone-delivered intervention improve outcomes more than diabetes education and support delivered via print materials alone? This aim compares the study arms on outcomes such as glycemic management (hemoglobin A1c), diabetes distress, and psychosocial well-being. This aim also compares the study arms on intervention targets (mediators) including diabetes self-efficacy and self-care behaviors. 2. For whom does the MOSAIC adaptive tailoring approach improve outcomes more than the print materials alone? This aim examines how well the tailoring rules used for the MOSAIC intervention worked for different participants on the outcomes examined in the first aim. Participants will enroll in a 16-month study with assessments every 4 months. Assessments include completion of an A1c test and a survey. For those assigned to MOSAIC, they will experience 12-months of mobile phone-delivered support with 3 opportunities for intervention tailoring.

Подробное описание

MOSAIC intervention components include:

* Monthly coaching sessions (\~30 minutes each) - Persons with diabetes (PWD) will engage in goal setting and skill building relevant to their self-identified diet, exercise, and/or stress management goal * Daily one-way and interactive text messages to support the PWD in meeting their goal and supporting medication adherence * Weekly interactive text messages asking the PWD to reflect on goal progress followed by personalized feedback from their coach * The option to invite an adult support person (SP). SPs may be invited to participate in monthly phone coaching and/or receive text messages (3 one-way texts per week and one interactive text per week) pertaining to supporting the PWD, per the MOSAIC intervention adaptive tailoring rules

PWD participants will be randomized in a parallel design to the MOSAIC adaptive mobile phone-delivered intervention or to print materials alone. The study is powered to detect a 0.5% reduction in hemoglobin A1c. Analyses will examine effects during the intervention (4 and 8 months) and post-intervention (12 months) and sustained effects (16 months). Participants will be analyzed as randomized regardless of withdrawal from the intervention (i.e., intention-to-treat principals) and missing data will be imputed.

Вмешательства

  • Поведенческое MOSAIC
    All MOSAIC PWD participants receive monthly phone coaching following a semi-structured protocol plus daily automated text message support. MOSAIC uses the mobile phone-delivered structure and functionality developed for FAMS (NCT04347291). Tailoring rules novel to MOSAIC determine phone coaching protocol content, text message content, and the involvement of a SP. Semi-structured protocols used in prior studies (and in the case of NCT04334109 adapted for mobile phone-delivery) are employed. Per t
  • Поведенческое Print Materials
    Quality print materials about diabetes management provided upon enrollment and in quarterly study newsletters

Первичные конечные точки

  • Change in Hemoglobin A1c During Intervention Period [Срок оценки: Baseline and 4, 8, and 12 months post-baseline]
  • Change in Hemoglobin A1c Sustained Post-intervention Effects [Срок оценки: Baseline and 16 months post-baseline]
Вторичные конечные точки (4)
  • Change in Diabetes Distress During Intervention Period [Срок оценки: Baseline and 4, 8, and 12 months post-baseline]
  • Change in Diabetes Distress Sustained Post-intervention Effect [Срок оценки: Baseline and 16 months post-baseline]
  • Change in Psychosocial Well-being During Intervention Period [Срок оценки: Baseline and 4, 8, and 12 months post-baseline]
  • Change in Psychosocial Well-being Sustained Post-intervention Effect [Срок оценки: Baseline 16 months post-baseline]

Критерии участия

Критерии включения

PERSONS WITH DIABETES:

  • Speaks and reads in English
  • 18-75 years old
  • Diagnosed with type 2 diabetes
  • Receiving outpatient care from a partnering clinic
  • Community-dwelling (e.g., not in a nursing facility)
  • Prescribed at least one diabetes medication
  • Owns a mobile phone

SUPPORT PERSONS:

  • Speaks and reads in English
  • 18 years or older
  • Owns a mobile phone

Критерии исключения

PERSONS WITH DIABETES:

  • Unable to communicate by phone
  • Currently pregnant
  • Currently undergoing treatment for cancer (e.g., radiation, chemotherapy)
  • Diagnosed with end-stage renal disease
  • Receiving hospice services\*
  • Diagnosed with congestive heart failure
  • Diagnosed with dementia
  • Diagnosed with schizophrenia
  • Demonstrated an inability to receive and respond to a text
  • Does not take medication on his/her own/medication administered by someone else

SUPPORT PERSONS:

  • Demonstrated inability to receive \& respond to a text
  • Unable to communicate by phone

Критерии приведены из реестра в оригинале (на английском). Окончательную оценку соответствия проводит исследовательский центр.

Здоровые добровольцы: Нет

Дизайн исследования

Распределение
Рандомизированное
Модель
Параллельные группы
Маскирование
Простое слепое
Основная цель
Поддерживающая терапия

Центры проведения

США · 2 центра
  • University of Alabama at Birmingham — Birmingham
  • Vanderbilt University Medical Center — Nashville

Идентификаторы

NCT: NCT06828549 · 242066 · 1R01DK140190-01

Первоисточники (государственные реестры)

Открыть это исследование на ClinicalTrials.gov ↗